Suppr超能文献

通过TP-PCR对1型强直性肌营养不良症受累家庭成员进行前突变评估及遗传咨询。

Assessment of Premutation in Myotonic Dystrophy Type 1 Affected Family Members by TP-PCR and Genetic Counseling.

作者信息

Kumar Ashok, Agarwal Sarita, Pradhan Sunil

机构信息

Department of Genetics, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow 226014, India.

Department of Neurology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow 226014, India.

出版信息

Case Rep Med. 2014;2014:289643. doi: 10.1155/2014/289643. Epub 2014 Feb 23.

Abstract

Myotonic dystrophy type 1 (DM1) is caused by the expansion of an unstable CTG repeat located in the 3'-UTR of (DMPK) the DM protein kinase gene. Patients with DM1 have expansions of greater than 50 repeats and up to many thousands. In the present study we aimed to evaluate the utility of TP-PCR in diagnostics as well as the assessment of premutation carriers in proband families. Twenty-seven DM1 cases were enrolled (from twenty-six families) and the 13 families of these cases came forward for family screening. The patient group constitute 22 males and 5 females and the average age of onset was 32.8 years (range 17 to 52). All clinically diagnosed DM1 cases and their family members DNA samples were analyzed by TP-PCR. All the cases were found to be positive for the CTG repeat expansion. Among those five families, four had at least an asymptomatic carrier. In the remaining one family other than the proband none was found to be neither affected nor asymptomatic. We reconfirmed the utility of PCR based screening for DM1 as being reliable and rapid molecular test and it should be used as an initial screening test for all patients with DM and their family members for initial screening purpose.

摘要

1型强直性肌营养不良(DM1)由位于DM蛋白激酶基因(DMPK)3'-UTR的不稳定CTG重复序列扩增引起。DM1患者的重复序列扩增超过50次,最多可达数千次。在本研究中,我们旨在评估TP-PCR在诊断中的效用以及对先证者家族中前突变携带者的评估。纳入了27例DM1病例(来自26个家庭),其中13个家庭主动要求进行家族筛查。患者组包括22名男性和5名女性,平均发病年龄为32.8岁(范围17至52岁)。通过TP-PCR分析所有临床诊断为DM1的病例及其家庭成员的DNA样本。所有病例的CTG重复序列扩增均呈阳性。在这5个家庭中,有4个家庭至少有1名无症状携带者。在除先证者外的其余1个家庭中,未发现有受影响或无症状的个体。我们再次证实基于PCR的DM1筛查是一种可靠且快速的分子检测方法,应用于所有DM患者及其家庭成员的初步筛查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04da/3970441/9dc503f75e81/CRIM2014-289643.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验